Dynavax Technologies | L'Utile Operativo

Operating Profit Cambiamento Data
Adma Biologics USD -11941000 20.63M 2023-12
Amgen USD 1.27B 819M 2023-12
AstraZeneca USD 1.95B 502M 2023-09
Dynavax Technologies USD -8491000 13.61M 2023-12
Gilead Sciences USD 1.61B 1.01B 2023-12
Neurocrine Biosciences USD 141.2M 67.6M 2023-09
Pfizer USD -6551000000 3.61B 2023-12
Regeneron Pharmaceuticals USD 972.9M 138.1M 2023-12
Roche Holding CHF 9.76B 3.84B 2023-06
Sarepta Therapeutics USD -48342000 16.82M 2023-09
TG Therapeutics USD -12485000 127.27M 2023-12
Vertex Pharmaceuticals USD 1.04B 11.7M 2023-09



Dynavax Technologies L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Apr 2024.